We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Zogenix and Battelle Ink Marketing Agreement for DosePro(R) Drug Delivery Technology

News   Mar 30, 2012

 
Zogenix and Battelle Ink Marketing Agreement for DosePro(R) Drug Delivery Technology
 
 
 

RELATED ARTICLES

B Cells May Be More Important in Immunotherapy Than Previously Thought

News

Researchers have found evidence that B cells might play an important role in immunotherapy for melanoma. Currently, immunotherapy is primarily focused on T cells, but the results suggest that B cells could also provide an interesting research avenue.

READ MORE

Delivering Flecks of Precious Metal to Cancer Cells

News

Scientists have found a way to dispatch minute fragments of palladium inside cancerous cells. The metal could be used to aid cancer treatments.

READ MORE

Existing Drug “Blocks” Brain Tumor Growth

News

A compound molecule used for drug delivery of insulin could be used to treat glioblastoma, according to research conducted by a team from the the University of Georgia.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE